Theme: Measure Your Blood Pressure: Control It, Live Longer

Hypertension Congress 2022

Renowned Speakers

Hypertension Congress 2022

Hypertension Congress 2022 gladly reports the "10th World Congress on Hypertension,Cardiology, Primary Health and Patient Care" which will be held during October 25-26, 2022 Paris, France, Conference.

Hypertension Congress 2022 will lay a stage for every one of the researchers, elite educators, and cardiologists, nephrologist, endocrinologist, specialists, osteopathicians , bariatric, attendants, medical services experts to talk about a methodology for hypertension and finding, therapy and anticipation of raised circulatory strain.

Hypertension is genuinely normal among the human populace and is oft en unregulated; nonetheless, uncontrolled expansion in circulatory strain passes on the people in danger to foster heart infirmities. As indicated by a report by the World Health Organization in 2018, 1.1 billion individuals on the planet have a raised circulatory strain and under 1 out of 5 have it taken care of. Treatment of cardiovascular infection frequently requires the organization of various drugs for extensive stretches of time to patients liable to be old and experiencing a scope of co-horrible conditions. This Conference is devoted to affect conversations that advance developments and new viewpoints to the current examination connected with cardiovascular illnesses and hypertension.

Millennium Hotel Paris Charles De Gaulle Address: Zone Hôtelière 2 Allée Du Verger Roissy En France, 95700 Paris, France

 Track 1: Heart Diseases & Heart failure

Hypertension is the systemic condition accompanying high blood pressure. This remains as one of the common medical problems. High blood pressure is a common condition in which the long-term force of the blood against the artery walls is high enough that it may eventually cause health problems, such as heart failure, chronic kidney disease, coronary artery disease, Stroke, atrial fibrillation, vision loss, peripheral vascular disease and dementia. There are two types of high blood pressure, such as primary hypertension, it tends to develop gradually over many years whereas secondary hypertension tends to develop gradually over many years. People with high blood pressure may have symptoms of headache, shortness of breath, nosebleeds, dizziness, chest pain, visual changes, blood in the urine.


Cardiac Nursing is a registered nurse who specializes to work with patients who suffer from various conditions of the cardiovascular system. Cardiac nurses help to treat conditions such as unstable angina, cardiomyopathy, coronary artery disease and cardiac dysrhythmia under the direction of a cardiologist. Cardiac nurses also perform postoperative care on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health assessments. Cardiac nurses work in many different environments, including coronary care units, cardiac catheterization, intensive care units, operating theatres, cardiac rehabilitation centers, clinical research, cardiac surgery wards, cardiovascular intensive care units (CVICU), and cardiac medical wards.

Track 3: Pediatric & Geriatric Cardiology

High blood pressure in children and adolescents is one of the most common problems that the children are facing. They may contribute to premature atherosclerosis and the early development of Cardiovascular diseases. Pediatric hypertension can be either primary or secondary and they are categorized as prehypertension , stage 1  and stage 2 hypertension. 

Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of high blood pressure greater than 140/90 mm Hg in a pregnant woman. It occurs after 20 weeks of gestation and leads to a serious condition called preeclampsia, also referred to as toxemia. Due to this condition, it may prevent the placenta from receiving enough blood, which can cause low birth weight in the baby.
Resistant hypertension is defined as uncontrolled blood pressure elevating to approximately (>140/90 mm Hg) after treatment with three or more antihypertensive drugs, such patients are more likely to have a secondary cause and has a high risk of end-organ damage. ACE inhibitor (or an angiotensin receptor blocker), a diuretic and a calcium channel blocker preclude resistant hypertension, which must be ruled out before a diagnosis can be made.
Sexual dysfunction is difficulty experienced by an individual during any stage of sexual activity, including physical pleasure, desire, arousal or orgasm. The common risk factors associated with sexual dysfunction for men and women including individual general health status, cardiovascular disease, other genitourinary disease, psychiatric/psychological disorders, diabetes mellitus, other chronic disease, and socio-demographic conditions.
During the treatment of hypertension, antihypertensive drugs such as diuretics, potassium sparring diuretics and β-blockers are used, which results in erectile dysfunction. Sexual dysfunction disorders may be classified into four types: orgasm disorders, sexual desire disorders, arousal disorders and pain disorders.
Hypertension is an extremely common comorbid condition in diabetes which significantly reduces the risk of macrovascular and microvascular complications, including stroke, coronary artery disease, and peripheral vascular disease, retinopathy, nephropathy, and possibly neuropathy.  It majorly depends on obesity, age and ethnicity. The use of angiotensin-converting enzyme inhibitors may slow progression to kidney failure and cardiovascular mortality, but these agents are the preferred therapy for managing diabetes and hypertension.
Renal hypertension or renovascular hypertension is elevated blood pressure due to narrowing of the arteries that carry blood to the kidneys or the blockage in the arteries due to high cholesterol. This condition is also called renal artery stenosis. As a consequence of this condition the kidney organs release hormones to maintain a higher amount of sodium and water, which in turn causes blood pressure to rise. It is usually controlled by antihypertensive drugs or treatments like stenting, angioplasty and surgery on the blood vessels of the kidney.
Hypertensive heart disease refers to heart problems occurring due to elevated blood pressure that is present over an extended period of time. Without treatment of high blood pressure, symptoms of heart failure can develop. It may lead to the thickening of the muscles which ultimately results in the deficient of the oxygen, this may cause angina (chest pain). High blood pressure also ends up in thickening of the blood vessel walls. When combined with cholesterol deposits within the blood vessels, the chance of heart attack and stroke will increase. Hypertensive heart disease is that the leading cause of unwellness and death from high blood pressure.
Hypertension is the single most important risk factor for stroke, doubling the risk of stroke for each 20 mm Hg increase in systolic blood pressure (SBP). Although reducing the blood pressure can lower stroke risk by 30% to 40%
In comparison with other antihypertensive agents, angiotensin receptor blockers (ARB) provide additional protection against stroke and other Cardiovascular diseases.
The strain hypertension weakens the blood vessels and predisposes them to damage, results in the blockage. This causes an ischemic stroke and hypertension is the most important cause of this type of stroke and also transient ischemic attacks.
Obesity increases the risk of the development of hypertension. Obesity-associated arterial hypertension is characterized by stimulation of the sympathetic nervous system, reaction of the renin-angiotensin system, and sodium retention, among other abnormalities. Obesity is characterized with increased blood flow, vasodilatation, cardiac output, and hypertension. Although cardiac index does not increase, cardiac output and glomerular filtration rate do. However, renal sodium retention also increases, leading to the cause of hypertension.
The risk factors of hypertension are age, smoking, diet, alcohol, cholesterol level, diabetes, ethnicity, family history, obesity, sedentary lifestyle, medication, recreation drugs. Regular physical activity decreases the risk of cardiovascular disease including high blood pressure, diabetes, breast and colon cancer, and depression. The prevention of hypertension is possible based on correct lifestyle and nutrition, starting from childhood age. The mediation that are used to treat high blood pressure are Thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers, alpha blockers, alpha-beta blockers, beta blockers, aldosterone antagonists, renin inhibitors,  vasodilators, central-acting agents.
In 1991, the National High Blood Pressure Education Program (NHBPEP) estimated that in United States, 43.3 million adults had hypertension. Overall, approximately 20% of the world’s adults are estimated to have high blood pressure. The prevalence dramatically elevates in patients older than 60 years: In many countries, 50% of individuals in this age group have hypertension. Worldwide, approximately 1 billion people have hypertension, contributing to more than 7.1 million deaths per year.
Track 14: Cardiology
Cardiology is a branch of medicine dealing with disorders of the heart and also the parts of the circulatory system. The field includes medical diagnosis and treatment of coronary artery disease, heart failure, congenital heart defects, valvular heart disease and electrophysiology. The symptoms that indicates a heart problem includes, shortness of breath, changes in heart rate or rhythm, high blood pressure, dizziness, chest pains.
The term global means international. Thus Global mental health defines the international viewpoint on various aspects of mental health. Its overall aim is to strengthen mental health all over the world by providing information about the mental health conditions in all countries, and classifying mental health care requirements in order to develop economical interventions to fulfil those specific requirements. Global mental health puts priority on improving mental health and achieving fairness in mental health for all individuals worldwide by study, research and practice. Lately, the global mental health movement has met with some criticism. It has been labelled as a cover for the pharmaceutical companies searching for new consumers for psychiatric drugs. Mental disorders are considered as health conditions categorized by changes in state of mind, mood and behaviour that are associated with pain or potentially disability in working. Mental illness refers to all diagnosable mental disorders. Mental disorders are one of the most well-known causes for disability and may incorporate death in some cases.


As indicated by Statistics MRC, the Global Stroke Diagnostics and Therapeutics market is figured for $23,849.39 Million of every 2017 and is assessed to reach $49,698.68 Million by 2026 developing at a CAGR of 8.5% during the gauge time frame.

Factors like innovative headway, a developing maturing populace, and individuals impacted by diabetes, hypertension are inclining toward the market. Then again, expanding wellbeing consumption, cardiovascular illnesses and expanding tobacco clients are providing the market.

Hypertension is an ongoing ailment during which the circulatory strain is raised to an unsought level. Hypertension is an ongoing infection, which implies that a patient could have to require prescriptions daily for the remainder of his/her life. Subsequently, the interest for against hypertensive prescription is property and can increment with an ascent inside the assortment of target patients. Hostile to hypertensive medications were the second biggest treatment region in 2011 with the overall deals worth of over USD 40 billion, as per the globe Preview 2018 report by valuate drug organization.

A portion of the central participants adding to the overall enemy of hypertensive prescription market incorporate Novartis AG, Pfizer, Inc., Johnson and Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck and Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, and Takeda Pharmaceutical Company Limited.

This examination report investigations this market relying on its market sections, significant geologies, and current market patterns. Topographies examined under this investigation report incorporate

North America

Asia Pacific


Rest of the World

Hypertension Congress 2022 is one of the world's driving logical gatherings to be Considered as one of the main clinical gatherings regarding this matter on the planet, the meeting incorporates oral and banner introductions chose from abstracts presented by clinical and fundamental scientists, trailed by conversations drove by driving specialists. With specialists in the fields of hypertension and its relationship to heart and kidney sickness, stroke, stoutness, and hereditary qualities, participants will have the chance to associate with cross-disciplinary analysts from around the world.
This gathering likewise offers meetings explicitly intended to help students and early vocation agents, just as Clinical Practice Clinical Science subjects zeroed in on applying clinical science to the clinician's training and Primary Care programming committed to reasonable guidance for the Primary Care Provider (PCP) intrigued by clinical hypertension.

"9th World Congress on Hypertension, Cardiology, Primary Health and Patient Care" genially welcomes all members across the globe to go to the Webinar on November 29-30, 2021. This two-day occasion will cover Keynote meetings of driving specialists, general invite conferences, and banner introductions of analysts and different academicians.

Euro Hypertension 2021 will lay a phase for every one of the scientists, first class educators, and cardiologists, nephrologists, endocrinologists, advisors, osteopathicians, bariatric, chaperons, clinical benefits specialists to discuss a technique for hypertension and finding, treatment and avoidance of raised circulatory strain.

Hypertension is genuinely normal among the human populace and is frequently unregulated; nonetheless, an uncontrolled expansion in pulse passes on the people in danger to foster heart illnesses. As indicated by a report by the World Health Organization in 2018, 1.1 billion individuals on the planet have raised pulse and under 1 of every 5 have it taken care of. Treatment of cardiovascular contamination habitually requires the organization of different medications for broad time intervals to patients inclined to be old and encountering an extent of co-horrendous conditions. This Conference is devoted to affecting conversations that advance developments and new viewpoints to the current examination connected with cardiovascular illnesses and hypertension.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 25-26, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View